December 11, 2013

The Food and Drug Administration has approved the first generic versions of a drug used to treat depression and other conditions, the agency said.

January 29, 2013

Eli Lilly and Company reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

July 6, 2012

Eli Lilly announced that it has met Food and Drug Administration requirements for pediatric exclusivity for its antidepressant medication.

April 28, 2011

Drug maker Eli Lilly will get at least two more years of patent exclusivity on a drug used to treat depression, anxiety and pain resulting from diabetic neuropathy and fibromyalgia, thanks to a court order issued Wednesday.

November 29, 2010

A generic drug maker announced that the Food and Drug Administration has granted tentative approval for its version of a popular antidepressant.

November 4, 2010

The Food and Drug Administration has approved a new usage for a drug used to...

August 19, 2010

A Food and Drug Administration advisory committee has voted to recommend expanding the use of...

May 31, 2010

A new Consumer Reports health survey found that nearly 80% of respondents seeking treatment for...

March 17, 2010

Drugs stolen from an Eli Lilly warehouse in Connecticut Sunday unlikely are to make it...

February 2, 2010

A pain drug made by Eli Lilly & Co. “significantly” reduced chronic low back pain...

January 24, 2010

A hypothetical fibromyalgia drug that improved sleeping quality better than the top-selling drugs on the...

January 12, 2010

Four drug companies have received warnings from the Food and Drug Administration in the last...